Table 2.
|
T72-T0 log KRECs/mL difference |
T72-T0 log TRECs/mL difference |
---|---|---|
coefficient | coefficient | |
log KRECs/mL at T0 |
−0.39 [−0.795,0.0155]* |
n.i. |
log TRECs/mL at T0 |
n.i. |
−0.67 [−0.826,−0.514]‡ |
Age at T0 |
0.000488 [−0.0297,0.0307] |
0.00908 [−0.0367,0.0549] |
Viremia at T0 (log DNAcopies/mL) |
0.07 [−0.136,0.276] |
−0.0774 [−0.378,0.223] |
CD4 at T0 (cells/mL) |
0.000225 [−0.00117,0.00162] |
−0.00171 [−0.00363,0.000212]* |
CD4/CD8 at T0 |
0.548 [−0.451,1.55] |
−1.88 [−3.18,−0.585]† |
Therapy arm |
0.156 [−0.196,0.507] |
−0.0792 [−0.594,0.435] |
Infection duration before therapy start (years) |
−0.105 [−0.163,−0.0471]† |
−0.0753 [−0.172,0.0217] |
HCV coinfection | −0.131 [−0.634,0.372] | −0.470 [−1.141,0.200] |
95% confidence intervals are in square brackets; n.i.: not included in the model; * p <0.10; † p <0.01; ‡ p <0.001.